| Stage | DBD | % of rev | RNG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $994M | 100.00% | $676M | 100.00% | DBD ×1.47 |
| Gross profit | $247M | 24.86% | $494M | 73.12% | RNG +48.3pp |
| Operating income | $39M | 3.90% | $54M | 7.97% | RNG +4.1pp |
| Pre-tax income | $15M | 1.54% | $28M | 4.14% | RNG +2.6pp |
| Net income | $7M | 0.71% | $570M | 84.27% | RNG +83.6pp |
| Stage | DBD | RNG | Gap · A − B |
|---|---|---|---|
| Revenue | $994M100.00% | $676M100.00% | DBD ×1.47 |
| Gross profit | 24.86%$247M | 73.12%$494M | RNG +48.3pp |
| Operating income | 3.90%$39M | 7.97%$54M | RNG +4.1pp |
| Pre-tax income | 1.54%$15M | 4.14%$28M | RNG +2.6pp |
| Net income |
| 0.71%$7M |
| 84.27%$570M |
| RNG +83.6pp |